(secondQuint)Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure.

 Current treatment with modalities in Acute Liver Failure still carry unacceptable morbidity and mortality.

 It is hoped that by intervening with ELAD a patient will have an opportunity to be bridged to transplant or to avoid transplantation and to have their native liver recover.

.

 Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure@highlight

The purpose of this study is to determine if treatment with the ELAD Bioartificial Liver Assist Device is beneficial to patients in Acute Liver Failure either as a bridge to liver transplant or bridge to native liver recovery.

